Sanofi Long-Term Concentrated

Location: Paris, France

CIK: 0001121404 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 4, 2025

Total Value: $260M (100.0% shares, 0.0% debt)

Holdings (9)

MGTX MeiraGTx Holdings plc 38.6%

Value $100M Shares 12,197,737 Est. Cost $5.86 Unrealized +34.9%

NVAX Novavax 22.9%

Value $59.65M Shares 6,880,481 Est. Cost $9.64 Unrealized -19.3%

INBX Inhibrx Biosciences, Inc. 15.0%

Value $39M Shares 1,157,926 Est. Cost $15.23 Unrealized +61.6%

ANAB AnaptysBio 9.7%

Value $25.17M Shares 821,917 Est. Cost $24.22 Unrealized -5.3%

IMRX Immuneering Corp 7.3%

Value $18.96M Shares 2,708,559 Est. Cost $5.19 Unrealized 0.0%

OMDA Omada Health Inc. 4.5%

Value $11.61M Shares 524,903 Est. Cost $17.31 Unrealized +18.3%

— LAVA Therapeutics N.V. 1.2%

Value $2.994M Shares 1,919,455 Est. Cost $0.95 Unrealized —

ELDN Eledon 0.8%

Value $2.111M Shares 814,980 Est. Cost $3.94 Unrealized -25.9%

QTTB Q32 Bio Inc. 0.2%

Value $483K Shares 244,083 Est. Cost $31.58 Unrealized -93.9%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MGTX	MeiraGTx Holdings plc	12,197,737	$100M	38.6%	$5.86	+34.9%	COM	G59665102
NVAX	Novavax	6,880,481	$59.65M	22.9%	$9.64	-19.3%	COM NEW	670002401
INBX	Inhibrx Biosciences, Inc.	1,157,926	$39M	15.0%	$15.23	+61.6%	COM	45720N103
ANAB	AnaptysBio	821,917	$25.17M	9.7%	$24.22	-5.3%	COM	032724106
IMRX	Immuneering Corp	2,708,559	$18.96M	7.3%	$5.19	0.0%	CLASS A COM	45254E107
OMDA	Omada Health Inc.	524,903	$11.61M	4.5%	$17.31	+18.3%	COM	68170A108
—	LAVA Therapeutics N.V.	1,919,455	$2.994M	1.2%	$0.95	—	SHS	N51517105
ELDN	Eledon	814,980	$2.111M	0.8%	$3.94	-25.9%	COM	28617K101
QTTB	Q32 Bio Inc.	244,083	$483K	0.2%	$31.58	-93.9%	COM	746964105